Memorial Sloan Kettering Cancer Center.
cancer treatment and research institution in New York City, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 2,020
What's happening
Earlier this month
-
MSKCC director Rudin presented trial data involving Amgen on October 25, 2026.Some support1 report
-
Moderna presented vaccine results at the ESMO meeting in Madrid, with RBC Capital Markets covering the company.Some support1 report
-
The FDA approved GSK's Jemperli drug, while Memorial Sloan Kettering Cancer Center was involved in the AZUR-1 trial.Some support2 reports
-
Estée Lauder's Chairman supports cancer research, and Larry Norton is named founding scientific director at Memorial Sloan Kettering.Some support1 report
-
Prelude Corporation's genomic test has been adopted in various US centers and is driving clinical decision-making, affiliated with Memorial Sloan Kettering Cancer Center.Some support2 reports1 development inside
One to three months ago
-
A study was published in the AACR journal, highlighting the clinical and oncology leadership at Memorial Sloan Kettering Cancer Center.Some support1 report
-
Donald Trump appointed Michael Caputo to a Cancer Panel at Memorial Sloan Kettering Cancer Center, replacing Mitchel S. Berger.Some support1 report
-
MoU signed between Memorial Sloan Kettering Cancer Center and a Ministry of Public Health for a new cancer treatment hospital.Well supported5 reports
-
Dr. Nicole Saphier, a radiologist, is reported to have invested in Coca-Cola and promoted products via Amazon and Instagram.Some support1 report
-
Memorial Sloan Kettering Cancer Center and the American Cancer Society are involved in cancer care, with Martin Voss serving as the oncologist at the center in New York City.Some support1 report1 development inside
-
Moderna, Memorial Sloan Kettering Cancer Center, and American Cancer Society are developing personalized cancer vaccine technology.Some support1 report
Gone quiet
No new reports in 90+ days-
Mayo Clinic and Memorial Sloan Kettering Cancer Center both treat serious cancer cases.Some support1 report1 development inside
-
Hartford HealthCare and Memorial Sloan Kettering Cancer Center utilize Cadence for remote patient monitoring.Some support1 report
-
Novartis and Memorial Sloan Kettering Cancer Center announce a clinical trial partnership and gain FDA approval for Pluvicto in prostate cancer.Some support2 reports
-
HHC Cancer Institute is leveraging a strategic partnership with Memorial Sloan Kettering Cancer Center, while Boruchov has succeeded Yu as physician-in-chief.Some support1 report
-
Memorial Sloan Kettering Cancer Center donated a mobile medical unit to Bethel Free Health Clinic to assist with its care resources.Some support1 report
-
David Faleck, a Principal Investigator at Memorial Sloan Kettering Cancer Center, is collaborating with a company to develop treatments for ICI side effects.Some support1 report
-
Tempus and Memorial Sloan Kettering Cancer Center launched an open-source digital pathology consortium.Some support1 report
-
Tempus AI is accelerating foundation model development by utilizing digital slide archives from Memorial Sloan Kettering Cancer Center and Microsoft Azure.Some support1 report
-
Clinical trials for cancer indications are underway at Memorial Sloan Kettering Cancer Center.Well supported3 reports
-
MSK is accelerating BriaCell's immunotherapy development by providing GMP manufacturing and regulatory support.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Memorial Sloan Kettering Cancer Center this week
News at the entities that move Memorial Sloan Kettering Cancer Center most-
Ministry of Public Health OperationalQatar University is a public university in Qatar, and the Ministry of Public Health operates within the state.Moves Memorial Sloan Kettering Cancer Center
-
Novartis StructuralBristol-Myers Squibb paused clinical trials following clinical setbacks reported by Novartis.Moves Memorial Sloan Kettering Cancer Center
-
GSK OperationalBoth GSK and Galderma operate within the pharmaceutical and biotech sectors.Moves Memorial Sloan Kettering Cancer Center
-
Moderna OperationalModerna and Arcturus Therapeutics are being compared for investment as healthcare companies.Moves Memorial Sloan Kettering Cancer Center
-
Tempus OperationalARK Innovation ETF holds major positions in high-tech companies including Tempus AI, Coinbase, SpaceX, OpenAI, Nvidia, and Tesla.Moves Memorial Sloan Kettering Cancer Center
-
Google DeepMind StructuralGoogle launched Gemini 4 Carbon, an AI model, to developers and businesses, noting its advanced reasoning capabilities.Moves Memorial Sloan Kettering Cancer Center
Connections
The 28 strongest of 2,020, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Ministry of Public Health Operational
A formal Memorandum of Understanding has been established between the center and the ministry to develop an integrated cancer treatment center.
-
Zsofia K. Stadler Structural
Zsofia K. Stadler serves as clinical director at Memorial Sloan Kettering Cancer Center.
-
Sean Barry Structural
Sean Barry served as the lead medical physicist for Memorial Sloan Kettering Cancer Center for 24 years.
-
Moderna Operational
Moderna and Memorial Sloan Kettering Cancer Center are actively partnering on personalized cancer vaccine trials and technology development.
-
Heather Landau Structural
Heather Landau is affiliated with Memorial Sloan Kettering Cancer Center as a specialist and lead investigator.
-
Novartis Structural
A functional clinical trial partnership exists between Memorial Sloan Kettering Cancer Center and Novartis, based on shared expert opinion and research goals.
-
Atif Khan Structural
Atif Khan serves as the Director of Memorial Sloan Kettering Cancer Center.
-
GSK Operational
MSKCC is actively involved in clinical trials and research collaborations with GSK.
Show all 28 connections
-
Martin Voss Structural
Martin Voss is employed as an oncologist at Memorial Sloan Kettering Cancer Center.
-
Tempus Operational
The two entities are currently collaborating in an open-source digital pathology consortium.
-
Carol L. Brown Structural
Carol L. Brown is employed as a surgeon at Memorial Sloan Kettering Cancer Center.
-
Larry Norton Structural
Larry Norton serves as the founding scientific director at Memorial Sloan Kettering Cancer Center.
-
Luis A. Diaz Structural
Luis A. Diaz holds a leadership position as head of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center.
-
Mayo Clinic Operational
Both institutions are major centers of excellence that compete for patients and research in the field of serious cancer care.
-
Hartford HealthCare Operational
The relationship is described as a functional partnership where one entity operates as a Care Partner to the other.
-
Google DeepMind Structural
Google DeepMind contributes scientific input to the research resources of Memorial Sloan Kettering Cancer Center.
-
company Operational
The relationship is characterized by a long history of operational collaboration between the center and the company.
-
Ken Griffin Transactional
Ken Griffin contributed to the new facility of Memorial Sloan Kettering Cancer Center.
-
David Faleck Structural
David Faleck holds the role of Principal Investigator at Memorial Sloan Kettering Cancer Center.
-
American Cancer Society Mentioned together
Both organizations are mentioned as being involved in the broader field of cancer care.
-
Estée Lauder Transactional
Estée Lauder supports cancer research conducted by Memorial Sloan Kettering Cancer Center.
-
New York City Shared context
MSKCC is physically situated within the geographic boundaries of New York City.
-
Qatar Operational
An MoU was established between MSK and Qatar to enhance cancer patient care in the region.
-
Michael Caputo Mentioned together
Michael Caputo participated in a panel alongside staff from Memorial Sloan Kettering Cancer Center.
-
Hancock County Shared context
Memorial Sloan Kettering Cancer Center is conducting contract negotiations within Hancock County.
-
New Jersey Shared context
Memorial Sloan Kettering Cancer Center is located within the state of New Jersey.
-
Uniondale Shared context
Memorial Sloan Kettering Cancer Center hosts clinical trials within the geographic context of Uniondale.
-
Amgen Mentioned together
No evidence provided linking Memorial Sloan Kettering Cancer Center and Amgen.
History
Events by the month they beganOctober 2026
6 events- MSKCC director Rudin presented trial data involving Amgen on October 25, 2026.
- Moderna presented vaccine results at the ESMO meeting in Madrid, with RBC Capital Markets covering the company.
- The FDA approved GSK's Jemperli drug, while Memorial Sloan Kettering Cancer Center was involved in the AZUR-1 trial.
- Estée Lauder's Chairman supports cancer research, and Larry Norton is named founding scientific director at Memorial Sloan Kettering.
- A study was published in the AACR journal, highlighting the clinical and oncology leadership at Memorial Sloan Kettering Cancer Center.
- Donald Trump appointed Michael Caputo to a Cancer Panel at Memorial Sloan Kettering Cancer Center, replacing Mitchel S. Berger.
September 2026
2 eventsAugust 2026
3 events- Moderna, Memorial Sloan Kettering Cancer Center, and American Cancer Society are developing personalized cancer vaccine technology.
- Mayo Clinic and Memorial Sloan Kettering Cancer Center both treat serious cancer cases.
- Hartford HealthCare and Memorial Sloan Kettering Cancer Center utilize Cadence for remote patient monitoring.
Show 2 earlier months
July 2026
3 events- Novartis and Memorial Sloan Kettering Cancer Center announce a clinical trial partnership and gain FDA approval for Pluvicto in prostate cancer.
- HHC Cancer Institute is leveraging a strategic partnership with Memorial Sloan Kettering Cancer Center, while Boruchov has succeeded Yu as physician-in-chief.
- Memorial Sloan Kettering Cancer Center donated a mobile medical unit to Bethel Free Health Clinic to assist with its care resources.
June 2026
7 events- Prelude Corporation's genomic test has been adopted in various US centers and is driving clinical decision-making, affiliated with Memorial Sloan Kettering Cancer Center.
- Memorial Sloan Kettering Cancer Center and the American Cancer Society are involved in cancer care, with Martin Voss serving as the oncologist at the center in New York City.
- David Faleck, a Principal Investigator at Memorial Sloan Kettering Cancer Center, is collaborating with a company to develop treatments for ICI side effects.
- Tempus and Memorial Sloan Kettering Cancer Center launched an open-source digital pathology consortium.
- Tempus AI is accelerating foundation model development by utilizing digital slide archives from Memorial Sloan Kettering Cancer Center and Microsoft Azure.
- Clinical trials for cancer indications are underway at Memorial Sloan Kettering Cancer Center.
- MSK is accelerating BriaCell's immunotherapy development by providing GMP manufacturing and regulatory support.